title: Postnatal penicillin prophylaxis of early-onset group B streptococcal infection in term newborns. A preliminary study.
abstract: BACKGROUND
  Early-onset group B Streptococcal disease (EOGBSD) is a serious but preventable neonatal infection. Maternal intrapartum antibiotic prophylaxis (IAP) does not prevent all cases of the disease. Management of asymptomatic neonates of GBS colonized mothers is problematic.
  
  
  OBJECTIVE
  The objective of this prospective study was to determine whether administration of intramuscular penicillin at birth to a strictly defined group of term newborns of GBS colonized mothers is an effective and safe method to prevent EOGBSD.
  
  
  METHODS
  A protocol for management of full-term infants born to GBS colonized mothers was created. Either an abnormality of blood count or presence of more than one obstetric risk factor were chosen as the indication criteria for administering postnatal antibiotic prophylaxis (PAP).
  
  
  RESULTS
  The study sample consists of 250 newborns (11.5% of all term infants). PAP was administered in 39 cases. Indication criteria included leucocytosis in 37 cases, leucopenia in 1 case and obstetric risk factors in 1 case. There was no case of clinically manifest infection, and no case of sepsis either suspect or proven.
  
  
  CONCLUSIONS
  The authors suggest that the strategy of selective PAP using penicillin, may be an effective and safe method in order to reduce morbidity and mortality from streptococcal infections. They recommend a combination of IAP and selective PAP.
authors: Clinic of Neonatology, Jessenius Faculty of Medicine, Comenius University, Faculty Hospital of Martin, Martin, Slovakia. luciastillova@gmail.com
authors: Lucia
authors: L
authors: Stillova
authors: Zuzana
authors: Z
authors: Strechova
authors: Katarina
authors: K
authors: Matasova
authors: Hana
authors: H
authors: Kolarovszka
authors: Kristina
authors: K
authors: Bodova
authors: Juraj
authors: J
authors: Stilla
authors: Mirko
authors: M
authors: Zibolen
mesh_terms: D019072:Antibiotic Prophylaxis; D006801:Humans; D007231:Infant, Newborn; D007273:Injections, Intramuscular; D010406:Penicillins / Q000627:therapeutic use*; D012307:Risk Factors; D013290:Streptococcal Infections / Q000517:prevention & control*; D013292:Streptococcus agalactiae
chemical_list: D010406:Penicillins